The European Union Council on Friday formally adopted new legislation aimed at protecting patients against the rising threat of falsified medicines. The new EU law is a major step forward in fighting falsified medicines in the region, the Council stated.
It introduces new harmonized, pan-European safety and control measures. It will introduce in particular for medicines exposed to the risk of falsification a new safety feature unique for each package. This will facilitate identifying falsified medicines before they are handed out to patients.
The Directive also introduces a common logo for legally operating on-line pharmacies. Once implemented, it would make it easier for patients throughout the EU to distinguish between legal and illegal on-line pharmacies. It will also tighten the control of the complex distribution chain of medicines by introducing strengthened requirements for EU and non-EU manufacturers of active substances as well as for wholesale distributors of medicinal products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze